Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Net Asset Value(s)

24 Sep 2025 07:37

RNS Number : 6012A
Fidelity Emerging Markets Limited
24 September 2025
 
Fidelity Emerging Markets Limited 
24 September 2025 
  
The Directors of Fidelity Emerging Markets Limited announce the following unaudited estimates as at 23 September 2025:
  
NAV (ex income)
984.93p
NAV (cum income)
1015.52p
Total Assets (ex income)
£629.463 million
Total Assets (cum income)
£649.014 million
  
  
Enquiries:  
  
Fidelity Investment International 
Phone + 44 ( 0) 1737 837846 
  
END  
  
Fidelity Emerging Markets Limited 
Source: Fidelity Emerging Markets Limited 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQZLBLEKLXBBD
Date   Source Headline
18th Mar 20267:55 amRNSNet Asset Value(s)
17th Mar 20265:15 pmPRNTransaction in Own Shares
17th Mar 20267:56 amRNSNet Asset Value(s)
16th Mar 20265:16 pmRNSTransaction in Own Shares
16th Mar 20265:16 pmPRNTransaction in Own Shares
16th Mar 20267:42 amRNSNet Asset Value(s)
13th Mar 20265:15 pmRNSTransaction in Own Shares
13th Mar 20265:15 pmPRNTransaction in Own Shares
13th Mar 20267:42 amRNSNet Asset Value(s)
13th Mar 20267:00 amRNSHalf-year Financial Report
13th Mar 20267:00 amPRNHalf-year Financial Report
12th Mar 20265:11 pmRNSTransaction in Own Shares
12th Mar 20265:11 pmPRNTransaction in Own Shares
12th Mar 20267:43 amRNSNet Asset Value(s)
11th Mar 20265:16 pmRNSTransaction in Own Shares
11th Mar 20265:16 pmPRNTransaction in Own Shares
10th Mar 20267:54 amRNSNet Asset Value(s)
9th Mar 20267:40 amRNSNet Asset Value(s)
6th Mar 20265:37 pmPRNTransaction in Own Shares
6th Mar 20267:55 amRNSNet Asset Value(s)
5th Mar 20268:00 amRNSNet Asset Value(s)
4th Mar 20267:56 amRNSNet Asset Value(s)
3rd Mar 20263:57 pmPRNHolding(s) in Company
3rd Mar 202610:43 amPRNMonthly Factsheet
3rd Mar 20267:47 amRNSNet Asset Value(s)
2nd Mar 20263:53 pmPRNTotal Voting Rights
2nd Mar 20267:45 amRNSNet Asset Value(s)
27th Feb 20267:53 amRNSNet Asset Value(s)
26th Feb 20265:18 pmPRNTransaction in Own Shares
26th Feb 20267:44 amRNSNet Asset Value(s)
25th Feb 20267:47 amRNSNet Asset Value(s)
24th Feb 20265:21 pmPRNTransaction in Own Shares
24th Feb 20267:37 amRNSNet Asset Value(s)
23rd Feb 20265:16 pmPRNTransaction in Own Shares
23rd Feb 202612:13 pmPRNHolding(s) in Company
23rd Feb 20267:40 amRNSNet Asset Value(s)
20th Feb 20265:19 pmPRNTransaction in Own Shares
20th Feb 20267:58 amRNSNet Asset Value(s)
19th Feb 20267:59 amRNSNet Asset Value(s)
18th Feb 20265:12 pmPRNTransaction in Own Shares
18th Feb 20267:51 amRNSNet Asset Value(s)
17th Feb 20267:47 amRNSNet Asset Value(s)
16th Feb 20267:54 amRNSNet Asset Value(s)
13th Feb 20267:54 amRNSNet Asset Value(s)
12th Feb 20265:13 pmPRNTransaction in Own Shares
12th Feb 20264:16 pmPRNHolding(s) in Company
12th Feb 20267:51 amRNSNet Asset Value(s)
11th Feb 20267:56 amRNSNet Asset Value(s)
10th Feb 20265:04 pmPRNTransaction in Own Shares
10th Feb 20267:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.